Key factor for successful therapeutic vaccination against chronic hepatitis B identified: Our colleagues in Munich found that the success of therapeutic hepatitis B vaccination depends on efficient priming of HBV-specific CD4 T cells. The results have been published in the Journal of Hepatology.